Early outcomes in CAP: clinical stability, clinical failure and nonresolving pneumonia

Stefano Aliberti, Paola Faverio

Source: Eur Respir Monogr 2014; 63: 205-218
Disease area: Respiratory infections

Full text journal articleCongress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Stefano Aliberti, Paola Faverio. Early outcomes in CAP: clinical stability, clinical failure and nonresolving pneumonia. Eur Respir Monogr 2014; 63: 205-218

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
I like clinical pulmonary infection scores to define the role of clinical evaluation to diagnose pneumonia and ventilator-associated pneumonia
Source: Annual Congress 2009 - Diagnosis of ventilator-associated pneumonia: challenge the dogmas!
Year: 2009


Incidence of severe sepsis as a cause of clinical failure in patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2007; 30: Suppl. 51, 42s
Year: 2007

Copeptin predicts early clinical deterioration and persistent instability in community-acquired pneumonia
Source: Annual Congress 2012 - Prognostic indices in respiratory infections
Year: 2012

Clinical outcome and prognostic factors of acute respiratory failure due to pneumocystis pneumonia in non-HIV patients
Source: Annual Congress 2012 - Infections and sepsis in the ICU
Year: 2012

Steroids are not associated with an improvement in clinical outcomes in hospitalized patients with community-acquired pneumonia (CAP)
Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections
Year: 2009

Community acquired pneumonia and co-existing acute kidney injury have poor clinical outcomes
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016

Potential protective role of prior to diagnosis antibiotic treatment in community-acquired pneumonia: Clinical presentation and outcomes
Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections
Year: 2011


Effect of corticoids on the clinical course and outcome of severe community-acquired pneumonia
Source: Annual Congress 2004 - SARS and other lower respiratory tract infections
Year: 2004

Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: A randomized clinical trial
Source: International Congress 2015 – Acute critical care: news from the ICU
Year: 2015



Initial and persistent inflammatory response in treatment failure in community-acquired pneumonia
Source: Annual Congress 2007 - Prognostic laboratory tests in community-acquired pneumonia
Year: 2007


Biomarkers in severe community-acquired pneumonia (SCAP) prognosis, complications and outcomes
Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia
Year: 2011


An unbalanced inflammatory response on admission impacts clinical stability in hospitalized patients with community-acquired pneumonia (CAP)
Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia
Year: 2011


Prediction of complications development and lethal outcome in patients with community-acquired pneumonia
Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura
Year: 2011


Clinical factors associated with delayed diagnosis in hospitalized community-acquired pneumonia (CAP). Impact on the outcome
Source: Annual Congress 2010 - Risk factors and outcomes in community-acquired pneumonia
Year: 2010



Procalcitonin and D-dimer to predict prognosis and clinical outcomes in severe community-acquired pneumonia (SCAP) patients
Source: Annual Congress 2012 - Respiratory infections: a clinical point of view
Year: 2012


Changes in empirical initial antibiotic therapy in community-acquired pneumonia: assessment of clinical failure versus discordant therapy
Source: Eur Respir J 2006; 28: Suppl. 50, 736s
Year: 2006

Clinical features and outcome of COVID-19 pneumonia in haemodialysis patients
Source: Virtual Congress 2021 – Diagnosis and management of COVID-19
Year: 2021


Initial management of pneumonia and sepsis: factors associated with improved outcome
Source: Eur Respir J 2011; 39: 156-162
Year: 2012



Initial management of pneumonia and sepsis: factors associated with improved outcome
Source: Eur Respir J 2012; 39: 156-162
Year: 2012



Predictors of clinical failure in community-acquired pneumonia
Source: Annual Congress 2011 - PG9 Risk stratification and treatment of lower respiratory tract infections
Year: 2011